Evelien Gielen Selected Research

Evelien Gielen Research Topics

Disease

13	Osteoporosis 06/2022 - 01/2011
9	Sarcopenia 12/2021 - 05/2013
5	Neoplasms (Cancer) 06/2022 - 08/2013
4	Cognitive Dysfunction 01/2022 - 06/2017
3	Vitamin D Deficiency 01/2022 - 09/2012
3	Bone Resorption 01/2020 - 01/2011
3	Frailty 01/2019 - 05/2013
3	Osteoporotic Fractures 12/2014 - 01/2011
2	Delirium 01/2022 - 01/2022
2	Dementia (Dementias) 01/2022 - 09/2017
2	Breast Neoplasms (Breast Cancer) 01/2020 - 11/2017
2	Inflammation (Inflammations) 06/2019 - 03/2014
2	Paralysis (Palsy) 12/2016 - 01/2016
2	Secondary Hyperparathyroidism 09/2012 - 01/2011
1	Lung Neoplasms (Lung Cancer) 06/2022
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Malnutrition (Nutritional Deficiencies) 01/2022
1	Chronic Renal Insufficiency 01/2022
1	Pressure Ulcer (Bedsore) 01/2022
1	Hypoalbuminemia 01/2022
1	Femoral Fractures (Femoral Fracture) 07/2020
1	Hip Fractures (Intertrochanteric Fractures) 07/2020
1	Hypophosphatasia 07/2020
1	Seizures (Absence Seizure) 07/2020
1	Postmenopausal Osteoporosis 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Insulin Resistance 06/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Muscular Atrophy (Muscle Atrophy) 12/2016
1	Metabolic Bone Diseases (Osteopenia) 12/2016
1	Body Weight (Weight, Body) 12/2016
1	Stroke (Strokes) 01/2016
1	Cachexia 01/2016
1	Osteitis Deformans (Paget's Disease of Bone) 03/2014
1	Metabolic Diseases (Metabolic Disease) 08/2013
1	Hypogonadism (Hypergonadotropic Hypogonadism) 08/2013
1	Cardiovascular Infections 08/2013

Drug/Important Bio-Agent (IBA)

7	Vitamin D FDA LinkGeneric 09/2017 - 01/2011
5	Denosumab FDA Link 06/2022 - 11/2017
5	CalciumIBA 01/2022 - 01/2011
4	GlucocorticoidsIBA 01/2022 - 01/2011
4	25-hydroxyvitamin DIBA 09/2017 - 05/2013
3	Diphosphonates (Bisphosphonates)IBA 07/2020 - 06/2011
3	AndrogensIBA 01/2020 - 03/2014
3	1,25-dihydroxyvitamin DIBA 09/2017 - 08/2013
3	hydroxide ionIBA 09/2017 - 05/2013
3	SteroidsIBA 01/2016 - 03/2014
2	romosozumabIBA 01/2022 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2022 - 08/2013
2	Hormones (Hormone)IBA 01/2022 - 09/2015
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2022 - 09/2015
2	C-Reactive ProteinIBA 12/2021 - 06/2017
2	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2019
2	Aromatase InhibitorsIBA 01/2020 - 11/2017
2	Anabolic AgentsIBA 06/2019 - 06/2011
2	MyostatinIBA 01/2019 - 01/2016
2	Zoledronic Acid (Zometa)FDA Link 11/2017 - 03/2014
2	Insulin-Like PeptidesIBA 01/2016 - 03/2014
2	Parathyroid Hormone (Parathormone)IBA 07/2014 - 05/2013
2	Testosterone (Sustanon)FDA Link 08/2013 - 01/2011
1	A 19IBA 01/2022
1	AlbuminsIBA 12/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	EnzymesIBA 07/2020
1	Pyridoxine (Pyridoxin)FDA LinkGeneric 07/2020
1	Alkaline PhosphataseIBA 07/2020
1	N- (4'- fluorobutyrophenone)- 4- (4- chlorophenyl)pyridinium (HPP(+))IBA 07/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 06/2019
1	Proteins (Proteins, Gene)FDA Link 06/2019
1	Monoclonal AntibodiesIBA 01/2019
1	MineralsIBA 01/2019
1	Clodronic Acid (Clodronate)IBA 11/2017
1	activin receptor type II-A (activin A receptor, type II)IBA 01/2016
1	AntibodiesIBA 01/2016
1	Growth Hormone (Somatotropin)IBA 01/2016
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2015
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 03/2014
1	Estrogens (Estrogen)FDA Link 03/2014
1	Bone Density Conservation AgentsIBA 06/2011

Therapy/Procedure

5	Therapeutics 07/2020 - 06/2011
2	Home Nursing (Nursing, Home) 01/2022 - 01/2014
2	Fracture Fixation 01/2019 - 01/2014
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Activities of Daily Living (ADL) 01/2022
1	Resistance Training 06/2019
1	Drug Therapy (Chemotherapy) 11/2017
1	Intravenous Infusions 03/2014